IGEM:IMPERIAL/2007/Projects/Experimental Design/Phase1: Difference between revisions

From OpenWetWare
Jump to navigationJump to search
No edit summary
No edit summary
Line 67: Line 67:
</div>
</div>


<div style="float:right; font-size: 150%;"><span class="_toggler_show-toggle1 _toggler-toggler1-2a _toggler-toggler1-2b toggler1-2a">Show All Details</span><span class="_toggler_hide-toggle1 _toggler-toggler1-2a _toggler-toggler1-2b toggler1-2b" style="display:none;">Hide All Details</span></div>
<div style="float:right; font-size: 150%;"><span class="_toggler_show-toggle1-1 _toggler-toggler1-1a _toggler-toggler1-1b toggler1-1a">Show All Details</span><span class="_toggler_hide-toggle1-1 _toggler-toggler1-1a _toggler-toggler1-1b toggler1-1b" style="display:none;">Hide All Details</span></div>


<br><br><br>
<br><br><br>
Line 125: Line 125:
*Positive Control: In vivo system with a large amount of AHL added.
*Positive Control: In vivo system with a large amount of AHL added.
</div>
</div>
<div style="float:right; font-size: 150%;"><span class="_toggler_show-toggle1-2 _toggler-toggler1-2a _toggler-toggler1-2b toggler1-2a">Show All Details</span><span class="_toggler_hide-toggle1-2 _toggler-toggler1-2a _toggler-toggler1-2b toggler1-2b" style="display:none;">Hide All Details</span></div>




Line 183: Line 185:
*Positive Control: In vitro system with purified GFP added
*Positive Control: In vitro system with purified GFP added
</div>
</div>
<div style="float:right; font-size: 150%;"><span class="_toggler_show-toggle2-1 _toggler-toggler2-1a _toggler-toggler2-1b toggler2-1a">Show All Details</span><span class="_toggler_hide-toggle2-1 _toggler-toggler2-1a _toggler-toggler2-1b toggler2-1b" style="display:none;">Hide All Details</span></div>


<br><br><br>
<br><br><br>
Line 243: Line 247:
*Positive Control: In vitro system with purified GFP added
*Positive Control: In vitro system with purified GFP added
</div>
</div>
<div style="float:right; font-size: 150%;"><span class="_toggler_show-toggle2-2 _toggler-toggler2-2a _toggler-toggler2-2b toggler2-2a">Show All Details</span><span class="_toggler_hide-toggle2-2 _toggler-toggler2-2a _toggler-toggler2-2b toggler2-2b" style="display:none;">Hide All Details</span></div>

Revision as of 04:01, 15 August 2007



1. Initial Promoter Testing - IN VIVO


1.1 Initial testing for Cell by Date

Status
Planned for 15/8/07 INCOMPLETE


Constructs: pTet-GFP, pT7-GFP, pcI-GFP


Test to see if construct will express in vivo. Experiments carried out at 30°C in an incubator.

Protocol
Results


Aims:

  • To determine if construct expresses in vivo
  • To get approximations of: life span, response time and rate of GFP synthesized.
  • To determine whether the constructs actually work before testing them in vitro.

[+] Constant Conditions

[+] Variables

[+] Sampling

[+] Controls

Show All Details






1.2 Initial testing for Infector Detector


Status
Planned for 15/8/07 INCOMPLETE


Construct: pTet - LuxR - pLux - GFP

Test to see if construct will express in vivo. Experiments carried out in incubator at 30oC at a range of inducer concentrations. To do this, we induce E. coli cells transfected with the construct with known concentrations of AHL. We then record the change in GFP, such that we can calculate the rate of GFP production relative to concentration of AHL in solution.

Protocol
Results


Aims:

  • To determine if construct expresses GFP in vivo
  • To determine the rate of change of protein production relative to concentration of AHL
  • To determine whether the constructs need to be optimised before testing in vitro.

[+] Constant Conditions

[+] Variables

[+] Sampling

[+] Controls

Show All Details


2. Initial Promoter Testing - IN VITRO


2.1 Initial Testing for Cell by Date


Status
Planned for 17/8/07 INCOMPLETE


Constructs: pTet-GFP, pT7-GFP, pcI-GFP


Test to see if construct will express in vitro. Experiments carried out at 30°C in an incubator.

Protocol
Results


Aims:

  • To determine if construct expresses in vitro
  • To get approximations of: life span, response time and rate of GFP synthesized.
  • To determine whether the constructs or the in vitro need to be optimised.

[+] Constant Conditions

[+] Variables

[+] Sampling

[+] Controls

Show All Details






2.2 Initial testing for Infector Detector


Status
Planned for 17/8/07 INCOMPLETE


Construct: pTet - LuxR - pLux - GFP


Test to see if construct will express in vitro. Experiments carried out at incubator at 30oC and under inducer concentration that was shown to give a high induction in vivo.

Protocol
Results


Aims:

  • To determine if construct expresses in vitro
  • To get approximations of: life span, response time and rate of GFP
  • To determine whether the constructs or the in vitro need to be optimised.

[+] Constant Conditions

[+] Variables

[+] Sampling

[+] Controls

Show All Details